Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029263 · ClinicalTrials.gov registry record · Phase 2
Screening Herbs for Drug Interactions
A Phase 2 study of Healthy, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT00029263: Completed Phase 2 study of Healthy, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00029263 is a Phase 2 study of Healthy that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 140 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029263, a Phase 2 study of Healthy, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to detect potential herb-drug interactions in volunteers.
Conditions Studied
Interventions
- DRUG herbals
Study Locations (1)
South Carolina
- Institute of Psychiatry, Medical University of SC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2001-08 |
| Est. Completion | 2004-05 |
| Phase | Phase 2 |
What the finished NCT00029263 record still lists
NCT00029263 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which herbals is the first listed.
NCT00029263 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00029263 about?
NCT00029263 is a clinical study titled "Screening Herbs for Drug Interactions". The purpose of this study is to detect potential herb-drug interactions in volunteers.
What is the current status of trial NCT00029263?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2001-08. Estimated completion is 2004-05.
What conditions does trial NCT00029263 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT00029263?
The interventions under investigation include: herbals (DRUG).
Who is sponsoring clinical trial NCT00029263?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00029263 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00029263's enrollment target sits among peer trials
140 165th of 1090 higher than 926 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Nasal Treatment for COVID-19
RECRUITING · Phase 2
-
Viral Mucosal Reprogramming
RECRUITING · Phase 2
-
Effects of an Antioxidant Supplement on Blood Vessel Health
RECRUITING · Phase 2
-
Atenolol for the Prevention of Osteoporosis (APO)
ACTIVE NOT RECRUITING · Phase 2
-
Effectiveness of Aquamin® in Mitigating Halitosis
ACTIVE NOT RECRUITING · Phase 2
-
Effects of Nitrite on Blood Vessel Dilation in Normal Volunteers
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia